What did AddLife pay for Vision Ophthalmology Group?

AddLife acquired Vision Ophthalmology Group for $195.7M in 2021 (12.7x EBITDA), equivalent to 2.40x revenue. Target revenue was approximately $83.0M. Target EBITDA was approximately $15.4M.

What does Vision Ophthalmology Group do?

Vision Ophthalmology Group is a medical devices business.

What multiple did AddLife pay for Vision Ophthalmology Group?

12.7x EBITDA and 2.40x revenue, based on disclosed deal value of $195.7M and disclosed financials.

M&A TRANSACTION · 2021

Vision Ophthalmology Group acquired by AddLife

$195.7M· 12.7x EBITDA· 2.40x revenue

Target

Vision Ophthalmology Group

Acquirer

AddLife

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$83.0M

EBITDA

$15.4M

Deal Value

$195.7M

EV/EBITDA

12.7x

Context

This $195.7M acquisition of Vision Ophthalmology Group by AddLife sits in the medical devices sub-vertical. The 12.7x EBITDA multiple paid in 2021 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. AddLife is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Vision Ophthalmology Group acquisition.

Citation: ExitValue.ai. (2021). Vision Ophthalmology Group acquired by AddLife. https://exitvalue.ai/deals/vision-ophthalmology-group-acquired-by-addlife-hc-2021-0103